Arun V. Ravindran, MD, PhD
Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Corresponding author: Arun V. Ravindran, MD, 100 Stokes St, Toronto, ON M6J 1H4 Canada ([email protected]).
Original Research
Quetiapine XR in Comorbid Depression and Anxiety
March 21, 2022
Quetiapine is often used off-label for anxiety and as an augmentation agent in treatment-resistant depression. This study evaluated the efficacy and tolerability of quetiapine in augmenting first-line antidepressants for...
Original Research
CAN-BIND-1 Outcomes and Early Response Prediction in MDD
February 5, 2019
Antidepressant medications are often prescribed with little certainty about their potential effectiveness in individual patients. Can early symptom reduction help predict later symptomatic and functional outcomes of antidepressant treatment?...
